breathe ilo is a revolutionary fertility tracking device that utilizes breath analysis technology to predict a woman's fertile days accurately. The device measures the carbon dioxide (CO2) levels in the user's breath, which correlate with hormone fluctuations during the menstrual cycle. As the levels of hormones like luteinizing hormone (LH) and progesterone change, the CO2 content in the breath decreases, particularly 4-5 days before ovulation.
breathe ilo's unique approach offers a non-invasive solution for fertility tracking, eliminating the need for invasive methods like basal body temperature measurement or urine testing. The device transmits the breath data to a smartphone app, which processes the information using a self-learning algorithm. This algorithm becomes more precise over time, enhancing the accuracy of fertility window predictions.
The breathe ilo device and app provide a comprehensive overview of the user's menstrual cycle, including fertile windows, period tracking, and symptom logging. The app also offers educational resources on women's health, enabling users to understand their bodies better.
breathe ilo's business model involves selling the fertility tracking device and accompanying app to consumers. The company had successfully launched in the German market and was preparing for international expansion, particularly targeting the US market in 2023.
In May 2023, breathe ilo partnered with ESCATEC, a manufacturing solutions provider, to scale up device production and meet the increasing global demand. ESCATEC's expertise in sourcing components, optimizing production lines, and ensuring compliance with medical device standards enabled breathe ilo to focus on product innovation and international growth.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.